Regional variation in patients and outcomes in the GLOBAL LEADERS trial-Reference-Cited by-同舟云学术

Regional variation in patients and outcomes in the GLOBAL LEADERS trial

Published:2021-02 Issue: Volume:324 Page:30-37
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Gao Chao,Takahashi Kuniaki,Garg Scot,Hara Hironori,Wang Rutao,Kawashima Hideyuki,Ono Masafumi,Montalescot Gilles,Haude Michael,Slagboom Ton,Vranckx Pascal,Valgimigli Marco,Windecker Stephan,Hamm Christian,Steg Philippe Gabriel,Storey Robert,van Geuns Robert-Jan,Tao Ling,Onuma Yoshinobu,Serruys Patrick W.

Funder

Servier

Biosensors International

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Ticagrelor versus clopidogrel in acute coronary syndromes;Wartak;N. Engl. J. Med.,2009

2. International differences in treatment effect: do they really exist and why?;Pocock;Eur. Heart J.,2013

3. Does geographical variability influence five-year MACCE rates in the multicentre SYNTAX revascularisation trial?;Roy;EuroIntervention,2017

4. Ticagrelor compared with clopidogrel by geographic region in the platelet inhibition and patient outcomes (PLATO) trial;Mahaffey;Circulation.,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention;Journal of Cardiovascular Development and Disease;2022-10-06

2. New balance to an old complex problem;Catheterization and Cardiovascular Interventions;2022-04-27

3. Outcomes and regional differences in practice in a worldwide coronary stent registry;Heart;2022-01-10

4. Aspirin-free antiplatelet regimens after PCI: insights from the GLOBAL LEADERS trial and beyond;European Heart Journal - Cardiovascular Pharmacotherapy;2021-04-30